Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: DUR-928 90 mg
Total 0 results
Nothing found
Sponsors and Collaborators
Universidad de Chile (UChile, Chile)
Washington State Attorney General's Office
mHealth Impact Lab
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
HMO Gesundheitsplan Basel, Switzerland
Stefano Rizza
Hoffmann-La Roche
Advanced Reconstructive Surgery Alliance
the Regional Direction of Clinical Research
Nuseed Americas Inc.
Pedro Rodrigues Genta
London Metropolitan University
Peijas Hospital
WillowWood Global LLC
IRCCS San Raffaele Roma
Marealis AS
Gynea Laboratorios SA
delta medical promotions ag
Hangzhou Neoantigen Therapeutics Co., Ltd.
Center for HIV/AIDS Vaccine Immunology
View Full List
Medical Conditions
Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms
Perforation of Eardrum.
Infantile GM2 Gangliosidosis (Disorder)
Mindfulness-based Intervention
Retinal Surgery
Orthopedics
Adult Oligoastrocytoma
Hypopigmented Skin
Shoulder Arthroscopy Blocks
Peroxisomal Disorders
Neoplasms, Urethral
Low-dose Corticosteroids Pretreatment
Type D Personality
Delivery
The Angle of Trunk Rotation in Thoracic Part
Philadelphia Chromosome
Deep Hypothermic Circulatory Arrest
Mitochondrial DNA Mutation
Urticaria Chronic
Congenital Heart Disease in Children
View Full List
Drug Interventions
Neridronate
Immediate-release nicotinamide (SAD)
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
Ibrutinib
Basiliximab
BIC/FTC/TAF
Simvastatin
Rituxumab
RhGM-CSF
Yohimbine hydrochloride
Silymarin (Silybum marianum)
Delamanid
Vincristine
Metronidazole
Etoposide
Atorvastatin
Amivantamab
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
Active Comparator: TU2670 320mg
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Colombia
Contract Research Organizations in Costa Rica
Contract Research Organizations in El Salvador
Contract Research Organizations in Georgia
Contract Research Organizations in Guinea
Contract Research Organizations in Ireland
Contract Research Organizations in Mozambique
Contract Research Organizations in Paraguay
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Trinidad & Tobago
Contract Research Organizations in Uruguay
CRO list by country
CROs in Belarus
Belnico
PRA Health Sciences
X7 Research
OCT Clinical
SGS
PSI
ICON
SanaClis
All CROs in Belarus
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe